This relationship between tau pathology and selective vulnerability, together with the concept that soluble tau oligomers are a primary toxic moiety, provides a framework for analyzing how toxic tau epitopes may contribute to selective vulnerability in AD. Here, MAPT is linked to Alzheimer disease.